First-pass extracted concept

electrochemical biosensors

Candidate: concept label1 source documents4 linked claims

Jump to evidence Jump to sources Jump to claims

Live refresh every 5sNext refresh in 5s

Evidence Snippets

Electrochemical, optical, and nanostructured platforms now enable real-time, label-free, and attomolar level detection of p‑Tau in biofluids and live cell models.

Evidence 1Source 1DOI PubMedprovenance

Supporting Sources

Source 1primary paper2025MEDDOI PubMed

1 evidence snippet 4 linked claims Claim 1 Claim 2 Claim 3

Linked Claims

Claim 1application scopesupports2025Source 1DOI PubMed

These biosensor systems are increasingly portable and suitable for point-of-care or in vivo applications.

Claim 2biomarker rolesupports2025Source 1DOI PubMed

Hyperphosphorylated Tau is a central biomarker for early diagnosis and disease monitoring in Alzheimer's disease.

Claim 3biosensor capabilitysupports2025Source 1DOI PubMed

Electrochemical, optical, and nanostructured biosensor platforms enable real-time, label-free, and attomolar-level detection of p-Tau in biofluids and live cell models.

Claim 4diagnostic performancesupports2025Source 1DOI PubMed

Various p-Tau epitopes have demonstrated superior diagnostic precision and form the molecular basis of updated Alzheimer's disease diagnostic frameworks.